EVO
Evotec SEBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
EVO vs peer average
70/100
EVO vs. peer average (B vs. C)
Grade spread
B 3 · C 4 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CRVS is the first available peer comparator.
Small-cap biotech risk comparator on size and financing sensitivity, but its clinical immuno-oncology model is not a direct peer to Evotec's discovery-and-development services platform.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EVO
Evotec SE
CRVS
Corvus
Grade
B
B
Momentum
98
79
Value
41
41
Sentiment
51
51
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CRVS
EVO / CRVS
Grade Position
Above peers
EVO vs. peer average (B vs. C)
70/100
Momentum
98
EVOValue
41
EVOSentiment
51
CRVSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EVO
CRVS is the first peer returned for this comparison set.